Special Purpose Needles Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2020 – 2030

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   India Skincare Dermacosmetics Market Year-on-Year Growth, 2021 - 2030 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        India Skincare Dermacosmetics Market by Application: Market Size and Forecast, 2020 – 2030

4.1    Overview

4.2  Dark Circles

4.2.1  Current Trend and Analysis

4.2.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.2.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.3  Skin Repair

4.3.1  Current Trend and Analysis

4.3.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.3.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.4  Scars

4.4.1  Current Trend and Analysis

4.4.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.4.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.5  Acne

4.5.1  Current Trend and Analysis

4.5.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.5.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.6  Psoriasis

4.6.1  Current Trend and Analysis

4.6.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.6.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

4.7  Wrinkles & Fine Line

4.7.1  Current Trend and Analysis

4.7.2  Market Size and Forecast, 2020 - 2030 ($ Million)

4.7.3  Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 5        India Skincare Dermacosmetics Market by Distribution Channel: Market Size and Forecast, 2020 – 2030

5.1  Overview

5.2  Drug Stores

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.2.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.3  Supermarkets & Hypermarkets

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.3.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

5.4  E-Commerce

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2020 - 2030 ($ Million)

5.4.3   Market Size and Forecast by Region, 2020 - 2030 ($ Million)

Chapter 6        Company Profiles 

6.1  HEGDE & HEGDE PHARMACEUTICA LLP

6.1.1     Company Overview

6.1.2     Product Portfolio

6.1.3     Business Strategies

6.1.4     Financials

6.1.5     Recent Developments

6.2  Honasa Consumer Private Limited (The Derma Co.)

6.2.1     Company Overview

6.2.2     Product Portfolio

6.2.3     Business Strategies

6.2.4     Financials

6.2.5     Recent Developments

6.3  Galderma SA

6.3.1     Company Overview

6.3.2     Product Portfolio

6.3.3     Business Strategies

6.3.4     Financials

6.3.5     Recent Developments

6.4  NAOS

6.4.1     Company Overview

6.4.2     Product Portfolio

6.4.3     Business Strategies

6.4.4     Financials

6.4.5     Recent Developments

6.5  Abbott Laboratories

6.5.1     Company Overview

6.5.2     Product Portfolio

6.5.3     Business Strategies

6.5.4     Financials

6.5.5     Recent Developments

6.6  Cadila Healthcare Ltd. (Zydus Cadila)

6.6.1     Company Overview

6.6.2     Product Portfolio

6.6.3     Business Strategies

6.6.4     Financials

6.6.5     Recent Developments

6.7  Cadila Pharmaceuticals Limited

6.7.1     Company Overview

6.7.2     Product Portfolio

6.7.3     Business Strategies

6.7.4     Financials

6.7.5     Recent Developments

6.8  Piramal Enterprises Limited

6.8.1     Company Overview

6.8.2     Product Portfolio

6.8.3     Business Strategies

6.8.4     Financials

6.8.5     Recent Developments

6.9  Torrent Pharmaceuticals Ltd.

6.9.1     Company Overview

6.9.2     Product Portfolio

6.9.3     Business Strategies

6.9.4     Financials

6.9.5     Recent Developments

6.10       Johnson & Johnson

6.10.1   Company Overview

6.10.2   Product Portfolio

6.10.3   Business Strategies

6.10.4   Financials

6.10.5   Recent Developments

6.11       Sebapharma GmbH & Co. KG

6.11.1   Company Overview

6.11.2   Product Portfolio

6.11.3   Business Strategies

6.11.4   Financials

6.11.5   Recent Developments

6.12       Dr. Reddy’s Laboratories Ltd.

6.12.1   Company Overview

6.12.2   Product Portfolio

6.12.3   Business Strategies

6.12.4   Financials

6.12.5   Recent Developments

6.13       ITC Limited

6.13.1   Company Overview

6.13.2   Product Portfolio

6.13.3   Business Strategies

6.13.4   Financials

6.13.5   Recent Developments